Cesar A. De Las Casas, MD, MPH, GRACE Faculty

Twitter Feed
Oncologist
Memorial Cancer Institute
Miami
FL
Specialties
Hematology and Oncology

Cesar A. De Las Casas, MD, MPH, board-certified hematologist and oncologist. He earned his medical degree from the Universidad Peruana Cayetano Heredia in Lima in 1994. He completed his internship in internal medicine at the Baylor College of Medicine in 1999, serving as Chief Medical Resident at St. Luke’s Episcopal Hospital in Houston and at Ben Taub Hospital in 1999 and 2000.

Conflict of Interest

None

GRACE sat down with Cesar A. De Las Casas, MD, MPH, to discuss information regarding if there a preferred induction therapy (¿¿Hay alguna terapia de inducción preferida?). Stay tuned for more on our continuing video series with our Spanish speaking faculty on updates in blood cancer treatments, and Multiple Myeloma, (Mieloma Múltiple).


Transcription:

¿Hay alguna terapia de inducción preferida?

GRACE sat down with Cesar A. De Las Casas, MD, MPH, to discuss information regarding the new antibodies for multiple myeloma (MM) therapy (¿Cuáles son los anticuerpos nuevos para la terapia del mieloma múltiple (MM)?). Stay tuned for more on our continuing video series with our Spanish speaking faculty on updates in blood cancer treatments, and Multiple Myeloma, (Mieloma Múltiple). 


 

We would like to thank the following company for their support of this program:

 

GRACE sat down with Cesar A. De Las Casas, MD, MPH, to discuss information regarding whether all patients should receive an autologous transplant (¿Todos deberían de recibir un trasplante autólogo?). Stay tuned for more on our continuing video series with our Spanish speaking faculty on updates in blood cancer treatments, and Multiple Myeloma, (Mieloma Múltiple).


 

We would like to thank the following company for their support of this program:

GRACE sat down with Cesar A. De Las Casas, MD, MPH, to discuss information regarding if there is a best maintenance therapy (¿Existe una terapia de mantenimiento mejor sobre las demás?). Stay tuned for more on our continuing video series with our Spanish speaking faculty on updates in blood cancer treatments, and Multiple Myeloma, (Mieloma Múltiple).


 

We would like to thank the following company for their support of this program:

Forum Discussions

Original post date: 2022-02-21

Hi all -- share your cancer journey here and connect with others.  Cancer.gov has a good general description of Cholangiocarcinoma.  This rare disease has support information and programs that can be

Last Activity: Mon, 02/21/2022 - 11:15
Original post date: 2022-02-04

Keep your eye out for new Head and Neck information soon! 

Last Activity: Sat, 02/05/2022 - 12:12
Original post date: 2022-02-01

Gallbladder Cancer is a rare disease in which malignant cells form in the tissues of the gallbladder.  Bile duct cancer or cholangiocarcinoma is a rare disease in which malignant cells form in the

Last Activity: Tue, 02/01/2022 - 16:16
Original post date: 2021-11-24

The happiest of Thanksgiving to everyone! Thank you for being a part of GRACE!

Image
Happy Thanksgiving!
Last Activity: Thu, 12/02/2021 - 15:33
Original post date: 2021-01-07
The research team at Tulane University is conducting an online survey of individuals with cancer. 

GRACE has been asked to share information about an anonymous one-time online research study about

Last Activity: Thu, 01/07/2021 - 15:55

Comments

Post Date: 2022-04-12

You may find our clinical trial page helpful, also.  https://cancergrace.org/find-clinical-trials.  

Post Date: 2022-02-04

Keep your eye out for new Head and Neck information soon! 


This comment has been promoted to its

Post Date: 2021-12-02

Janine I am so happy to hear things like this. What you can or feel comfortable sharing, know that

Post Date: 2021-07-19

Hi all!  

The 2021 Targeted Therapies Patient Forum is now available ON Demand!  

Click below to